NASDAQ:APDN - Applied DNA Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.65 0.00 (0.00 %) (As of 03/22/2019 10:14 AM ET)Previous Close$0.6480Today's Range$0.6491 - $0.6852-Week Range$0.30 - $1.84Volume17,305 shsAverage Volume207,349 shsMarket Capitalization$23.60 millionP/E RatioN/ADividend YieldN/ABeta0.64 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Applied DNA Sciences, Inc. develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides DNAnet, Smart DNA, and Backtrac that are molecular tags to link evidence and offenders to specific crime scenes; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and highvalue assets through inks, varnishes, and coatings; and SigNify IF portable DNA readers that provides real-time authentication of molecular tags. In addition, the company offers Applied DNA Sciences Portal, a software platform that enables customers to manage the security of company-marked goods from point of marking to point of authentication or validation to end of life; and DNA Transfer Systems and Cannabis Tracking System, which offer remote Internet access for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Additionally, the company offers contract research services for the nucleic acid-based medical and biologic markets; and various RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York. Receive APDN News and Ratings via Email Sign-up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Miscellaneous business services Sub-IndustryN/A SectorIndustrial Products Current SymbolNASDAQ:APDN Previous Symbol CUSIPN/A CIK744452 Webwww.adnas.com Phone631-840-8800Debt Debt-to-Equity Ratio2.82 Current Ratio1.68 Quick Ratio1.60Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$3.90 million Price / Sales6.05 Cash FlowN/A Price / Cash FlowN/A Book Value$0.02 per share Price / Book32.46Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-11,690,000.00 Net Margins-283.98% Return on Equity-458.79% Return on Assets-178.98%Miscellaneous Employees59 Outstanding Shares36,360,000Market Cap$23.60 million Next Earnings Date5/2/2019 (Estimated) OptionableOptionable Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions What is Applied DNA Sciences' stock symbol? Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN." How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences Inc (NASDAQ:APDN) released its earnings results on Thursday, February, 7th. The technology company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.03. The technology company earned $0.88 million during the quarter. Applied DNA Sciences had a negative return on equity of 458.79% and a negative net margin of 283.98%. View Applied DNA Sciences' Earnings History. When is Applied DNA Sciences' next earnings date? Applied DNA Sciences is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Applied DNA Sciences. What price target have analysts set for APDN? 1 equities research analysts have issued twelve-month target prices for Applied DNA Sciences' shares. Their predictions range from $3.00 to $3.00. On average, they expect Applied DNA Sciences' share price to reach $3.00 in the next year. This suggests a possible upside of 362.2% from the stock's current price. View Analyst Price Targets for Applied DNA Sciences. What is the consensus analysts' recommendation for Applied DNA Sciences? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Applied DNA Sciences. Has Applied DNA Sciences been receiving favorable news coverage? Media stories about APDN stock have been trending somewhat positive on Friday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Applied DNA Sciences earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 7.0 out of 10, meaning that recent media coverage is likely to have an impact on the company's share price in the next few days. Are investors shorting Applied DNA Sciences? Applied DNA Sciences saw a increase in short interest in the month of February. As of February 15th, there was short interest totalling 1,914,989 shares, an increase of 31.0% from the January 31st total of 1,461,898 shares. Based on an average trading volume of 1,222,562 shares, the short-interest ratio is presently 1.6 days. Currently, 7.0% of the shares of the company are short sold. View Applied DNA Sciences' Current Options Chain. Who are some of Applied DNA Sciences' key competitors? Some companies that are related to Applied DNA Sciences include TENCENT HOLDING/ADR (TCEHY), Johnson Controls International (JCI), SEA (SE), NV5 Global (NVEE), Donnelley Financial Solutions (DFIN), Altisource Portfolio Solutions (ASPS), Performant Financial (PFMT), Helios and Matheson Analytics (HMNY), Ascent Capital Group Inc Series A (ASCMA), Cornerworld (CWRL) and Solis Tek (SLTK). What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Anavex Life Sciences (AVXL), Ekso Bionics (EKSO), TerraForm Global (GLBL), Viking Therapeutics (VKTX), Advanced Micro Devices (AMD), Catalyst Pharmaceuticals (CPRX), Inovio Pharmaceuticals (INO), Celldex Therapeutics (CLDX), Ampliphi Biosciences (APHB) and Sanchez Energy (SN). Who are Applied DNA Sciences' key executives? Applied DNA Sciences' management team includes the folowing people: Dr. James A. Hayward Ph.D., Sc.D., Pres, CEO & Chairman (Age 65)Ms. Beth M. Jantzen CPA, CPA, CFO & Principal Accounting Officer (Age 43)Ms. Judith Murrah, Chief Information Officer & Sec. (Age 61)Mr. Clay Shorrock Esq., Gen. CounselMr. Tony Benson, Managing Director of EMEA Who are Applied DNA Sciences' major shareholders? Applied DNA Sciences' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Chase Investment Counsel Corp (0.73%). View Institutional Ownership Trends for Applied DNA Sciences. Which institutional investors are buying Applied DNA Sciences stock? APDN stock was bought by a variety of institutional investors in the last quarter, including Chase Investment Counsel Corp. View Insider Buying and Selling for Applied DNA Sciences. How do I buy shares of Applied DNA Sciences? Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Applied DNA Sciences' stock price today? One share of APDN stock can currently be purchased for approximately $0.6491. How big of a company is Applied DNA Sciences? Applied DNA Sciences has a market capitalization of $23.60 million and generates $3.90 million in revenue each year. Applied DNA Sciences employs 59 workers across the globe. What is Applied DNA Sciences' official website? The official website for Applied DNA Sciences is http://www.adnas.com. How can I contact Applied DNA Sciences? Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected] MarketBeat Community Rating for Applied DNA Sciences (NASDAQ APDN)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 178 (Vote Outperform)Underperform Votes: 149 (Vote Underperform)Total Votes: 327MarketBeat's community ratings are surveys of what our community members think about Applied DNA Sciences and other stocks. Vote "Outperform" if you believe APDN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APDN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: What is a Backdoor Roth IRA?